Oktreotid Teva 20 mg prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem
| Name | Oktreotid Teva 20 mg prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-487108635 |
| Active Substance | oktreotidacetat |
| Composition | svaka bočica sadrži oktreotidacetat što odgovara 20 mg oktreotida |
| Pharmaceutical Form | prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem |
| Manufacturer | Merckle GmbH, Blaubeuren, Njemačka
Pliva Hrvatska d.o.o., Zagreb, Hrvatska Pharmathen International S.A., Rodopi, Grčka |
| Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
| Marketing Authorisation Date | 12.04.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/128 |
| Registration Number | 381-12-01/171-24-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | H01CB02 |
| Marketing status | Marketed |
| Shortage status | Actual |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
